Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
25%
Ph phase_3
1
25%
Ph not_applicable
2
50%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_1

Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma

NCT01165333
unknownnot_applicable

Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients

NCT02337036
completednot_applicable

Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain

NCT03174145
completedphase_3

Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT

NCT01006733

Clinical Trials (4)

Showing 4 of 4 trials
NCT01165333Phase 1

Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma

Completed
NCT02337036Not Applicable

Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients

Unknown
NCT03174145Not Applicable

Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain

Completed
NCT01006733Phase 3

Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT

Completed

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4